RICE HALL JAMES & ASSOCIATES, LLC
Position in PBH — Prestige Consumer Healthcare Inc.
CIK 1230765
San Diego, CA
Position in PBH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,916,535
+$34,521 QoQ
Shares Held
521,622
+4.2% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
1.72%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 74.9329974579293.ToString("F0")%
Shared 0.ToString("F0")%
None 25.067002542070693.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $163,984,394 across 13 Drug Manufacturers - Specialty & Generic names. PBH ranks #1 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
521,622 | $30,916,535 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
608,416 | $29,295,230 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
477,416 | $24,677,633 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,230,105 | $21,230,599 | |
| 5 | ALKS |
Alkermes plc.
|
390,344 | $13,802,563 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
99,990 | $13,172,682 | |
| 7 | HROW |
Harrow, Inc.
|
368,177 | $12,981,921 | |
| 8 | EOLS |
Evolus, Inc.
|
1,254,819 | $5,157,306 |
All Filings in PBH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,916,535 | 521,622 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,882,014 | 500,600 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $31,803,283 | 509,668 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $43,110,456 | 539,893 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $46,864,654 | 545,128 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $43,012,909 | 550,812 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $41,351,801 | 573,534 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $40,776,894 | 592,257 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $45,718,532 | 630,079 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $40,810,047 | 666,613 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $31,694,126 | 554,190 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $33,498,908 | 563,670 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $35,778,201 | 571,263 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $39,197,553 | 626,159 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $31,243,410 | 627,000 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $44,042,670 | 749,025 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $40,694,819 | 768,697 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $47,276,614 | 779,499 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $44,895,911 | 800,141 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $42,282,588 | 811,566 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $42,393,895 | 961,749 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $30,463,443 | 873,629 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $19,956,411 | 547,952 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $19,815,604 | 527,572 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $19,983,484 | 544,806 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||